Recanalization of chronically occluded aortocoronary saphenous vein bypass grafts by extended infusion of urokinase: initial results and short-term clinical follow-up

Midwest Cardiovascular Institute, Downers Grove, Illinois.

Chronic occlusion of saphenous vein aortocoronary bypass grafts is a common problem. Although percutaneous transluminal angioplasty of a saphenous vein with a stenotic lesion is feasible, angioplasty alone of a totally occluded vein graft yields uniformly poor results. Patients with such occlusion are often subjected to repeat aortocoronary bypass surgery. Experience with a new technique that allows angioplasty to be performed in a totally occluded saphenous vein bypass graft is reported. This technique utilizes infusion of prolonged low dose urokinase directly into the proximal portion of the occluded graft. Forty-six consecutive patients with 47 totally occluded grafts were studied. Patients had undergone end to side saphenous vein bypass grafting 1 to 13 (mean 7) years previously. All patients presented with new or worsening angina pectoris with ST-T changes or non-Q wave acute myocardial infarction and all had a totally occluded saphenous vein bypass graft. The new technique entailed the positioning of an angiographic catheter into the stub of the occluded graft and the advancement of an infusion wire into the graft. Patients were returned to the coronary care unit, where urokinase was delivered at a dose of 100,000 to 250,000 U/h. The total dose of urokinase ranged from 0.7 to 9.8 million U over 7.5 to 77 h (mean 31). After therapy, recanalization was seen in 37 (79%) of the 47 grafts. In 20 successfully treated patients, angiography was performed 1 to 24 (mean 11) months after treatment; 13 (65%) of these grafts were patent.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				A. E. Abbas, S. D. Brewington, S. R. Dixon, J. A. Boura, C. L. Grines, and W. W. O'Neill Intracoronary Fibrin-Specific Thrombolytic Infusion Facilitates Percutaneous Recanalization of Chronic Total Occlusion J. Am. Coll. Cardiol., September 6, 2005; 46(5): 793 - 798. [Abstract] [Full Text] [PDF]

				S. C. Smith Jr, J. T. Dove, A. K. Jacobs, J. Ward Kennedy, D. Kereiakes, M. J. Kern, R. E. Kuntz, J. J. Popma, H. V. Schaff, D. O. Williams, et al. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines): A report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions J. Am. Coll. Cardiol., June 15, 2001; 37(8): 2239 - 2239. [Full Text] [PDF]

				D. R. Holmes Jr and P. B. Berger Percutaneous Revascularization of Occluded Vein Grafts : Is It Still a Temptation to Be Resisted? Circulation, January 12, 1999; 99(1): 8 - 11. [Full Text] [PDF]

				U. Rosenschein, G. Gaul, R. Erbel, F. Amann, D. Velasguez, H. Stoerger, R. Simon, G. Gomez, J. Troster, A. Bartorelli, et al. Percutaneous Transluminal Therapy of Occluded Saphenous Vein Grafts : Can the Challenge Be Met With Ultrasound Thrombolysis? Circulation, January 12, 1999; 99(1): 26 - 29. [Abstract] [Full Text] [PDF]

				J. F. Mitchel, D. B. Fram, D. F. Palme II, R. Foster, J. A. Hirst, M. A. Azrin, L. M. Bow, A. M. Eldin, D. D. Waters, and R. G. McKay Enhanced Intracoronary Thrombolysis With Urokinase Using a Novel, Local Drug Delivery System : In Vitro, In Vivo, and Clinical Studies Circulation, February 1, 1995; 91(3): 785 - 793. [Abstract] [Full Text]